serum drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (7)
Papers in which this entity is mentioned.
- Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533. (2022)
- Detection and characterization of lung cancer using cell-free DNA fragmentomes. (2021)
- Polygenic prediction via Bayesian regression and continuous shrinkage priors. (2019)
- Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in -rearranged lung cancer. (2019)
- Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia. (2019)
- Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. (2015)
- Tackling the widespread and critical impact of batch effects in high-throughput data. (2010)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| serum | drug | 48 | 118 |
| 5% serum | drug | — | — |
| appropriate serum | drug | — | — |